Characterization of Small Molecules Inhibiting the Pro-Angiogenic Activity of the Zinc Finger Transcription Factor Vezf1.

Characterization of Small Molecules Inhibiting the Pro-Angiogenic Activity of the Zinc Finger Transcription Factor Vezf1.
复制标题

DOI:
10.3390/molecules23071615
复制
发表时间:
2018-07-03
期刊:
Molecules (Basel, Switzerland)
影响因子:
--
通讯作者:
Gowher H
Gowher H
中科院分区:
其他
文献类型:
--
作者:
He M;Yang Q;Norvil AB;Sherris D;Gowher H

文献摘要

参考文献

被引文献

相似文献

内皮相关转录因子抑制剂的发现有助于开发治疗包括癌症在内的各种疾病的抗血管生成疗法。一些早期研究已经明确了转录因子 Vezf1 在血管发育和血管生成调节中的作用。通过构建 Vezf1 的计算模型,这里的工作确定了一种新型小分子药物,能够抑制 Vezf1 与其同源 DNA 结合位点的结合。利用基于结构的设计和 NCI 多样性化合物库的虚拟筛选,使用电泳凝胶迁移率变动分析测试了 12 种入围化合物干扰 Vezf1 与 DNA 结合的能力。我们鉴定出一种化合物 T4,其 IC50 为 20 μM。使用小鼠内皮细胞 MSS31,我们通过管形成实验测试了 T4 对内皮细胞活力和血管生成的影响。我们的数据表明,在细胞培养基中添加 T4 在低于或等于其 IC 50 的浓度下不会影响细胞活力,但会在管形成测定中强烈抑制 MSS31 的网络形成。鉴于其潜在功效,该抑制剂在多种人类疾病中具有显着的治疗潜力。
Discovery of inhibitors for endothelial-related transcription factors can contribute to the development of anti-angiogenic therapies that treat various diseases, including cancer. The role of transcription factor Vezf1 in vascular development and regulation of angiogenesis has been defined by several earlier studies. Through construction of a computational model for Vezf1, work here has identified a novel small molecule drug capable of inhibiting Vezf1 from binding to its cognate DNA binding site. Using structure-based design and virtual screening of the NCI Diversity Compound Library, 12 shortlisted compounds were tested for their ability to interfere with the binding of Vezf1 to DNA using electrophoretic gel mobility shift assays. We identified one compound, T4, which has an IC50 of 20 μM. Using murine endothelial cells, MSS31, we tested the effect of T4 on endothelial cell viability and angiogenesis by using tube formation assay. Our data show that addition of T4 in cell culture medium does not affect cell viability at concentrations lower or equal to its IC 50 but strongly inhibits the network formation by MSS31 in the tube formation assays. Given its potential efficacy, this inhibitor has significant therapeutic potential in several human diseases.
DOI: 10.1074/jbc.m105166200
发表时间: 2001-10-19
影响因子: 4.8
作者:
Aitsebaomo, J;Kingsley-Kallesen, ML;Patterson, C
通讯作者: Patterson, C
DOI: 10.1161/atvbaha.109.200428
发表时间: 2010-07
期刊: Arteriosclerosis, thrombosis, and vascular biology
影响因子: --
作者:
Zou Z;Ocaya PA;Sun H;Kuhnert F;Stuhlmann H
通讯作者: Stuhlmann H
DOI: 10.1126/science.1092472
发表时间: 2004-02-06
期刊: SCIENCE
影响因子: 56.9
作者:
Vassilev, LT;Vu, BT;Liu, EA
通讯作者: Liu, EA
DOI: 10.1093/nar/18.17.5119
发表时间: 1990-09-11
影响因子: 14.9
作者:
CLARK, SP;LEWIS, CD;FELSENFELD, G
通讯作者: FELSENFELD, G
DOI: 10.1080/10623320500227101
发表时间: 2005-07-01
影响因子: --
作者:
Miyashita, H;Sato, Y
通讯作者: Sato, Y